Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Cholesterol ; 2013: 754580, 2013.
Article in English | MEDLINE | ID: mdl-23710353

ABSTRACT

Leishmania major infection of resistant mice causes a self-limited lesion characterized by macrophage activation and a Th1 proinflammatory response. Atherosclerosis is an inflammatory disease involving hypercholesterolemia and macrophage activation. In this study, we evaluated the influence of L. major infection on the development of atherosclerosis using atherosclerosis-susceptible apolipoprotein E-deficient (apoE KO) mice. After 6 weeks of infection, apoE KO mice exhibited reduced footpad swelling and parasitemia similar to C57BL/6 controls, confirming that both strains are resistant to infection with L. major. L. major-infected mice had increased plasma cholesterol levels and reduced triacylglycerols. With regard to atherosclerosis, noninfected mice developed only fatty streak lesions, while the infected mice presented with advanced lesions containing a necrotic core and an abundant inflammatory infiltrate. CD36 expression was increased in the aortic valve of the infected mice, indicating increased macrophage activation. In conclusion, L. major infection, although localized and self-limited in resistant apoE KO mice, has a detrimental effect on the blood lipid profile, increases the inflammatory cell migration to atherosclerotic lesions, and promotes atherogenesis. These effects are consequences of the stimulation of the immune system by L. major, which promotes the inflammatory components of atherosclerosis, which are primarily the parasite-activated macrophages.

2.
Nat Immunol ; 13(2): 136-43, 2012 Jan 08.
Article in English | MEDLINE | ID: mdl-22231519

ABSTRACT

Atherosclerotic plaque formation is fueled by the persistence of lipid-laden macrophages in the artery wall. The mechanisms by which these cells become trapped, thereby establishing chronic inflammation, remain unknown. Here we found that netrin-1, a neuroimmune guidance cue, was secreted by macrophages in human and mouse atheroma, where it inactivated the migration of macrophages toward chemokines linked to their egress from plaques. Acting via its receptor, UNC5b, netrin-1 inhibited the migration of macrophages directed by the chemokines CCL2 and CCL19, activation of the actin-remodeling GTPase Rac1 and actin polymerization. Targeted deletion of netrin-1 in macrophages resulted in much less atherosclerosis in mice deficient in the receptor for low-density lipoprotein and promoted the emigration of macrophages from plaques. Thus, netrin-1 promoted atherosclerosis by retaining macrophages in the artery wall. Our results establish a causative role for negative regulators of leukocyte migration in chronic inflammation.


Subject(s)
Atherosclerosis/immunology , Cell Movement/immunology , Macrophages/immunology , Nerve Growth Factors/metabolism , Plaque, Atherosclerotic/immunology , Tumor Suppressor Proteins/metabolism , Actins/metabolism , Animals , Cells, Cultured , Chemokine CCL19/metabolism , Chemokine CCL2/metabolism , Chimera/metabolism , Gene Deletion , Humans , Mice , Nerve Growth Factors/genetics , Netrin Receptors , Netrin-1 , Neuropeptides/metabolism , Polymerization , Receptors, Cell Surface/metabolism , Tumor Suppressor Proteins/genetics , rac GTP-Binding Proteins/metabolism , rac1 GTP-Binding Protein/metabolism
3.
Eur J Nutr ; 51(8): 927-37, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22086299

ABSTRACT

PURPOSE: Extracts of the mushroom Agaricus blazei (A. blazei) have been described as possessing immunomodulatory and potentially cancer-protective activities. However, these effects of A. blazei as a functional food have not been fully investigated in vivo. METHODS: Using apolipoprotein E-deficient (ApoE(-/-)) mice, an experimental model of atherosclerosis, we evaluated the effects of 6 or 12 weeks of A. blazei supplementation on the activation of immune cells in the spleen and blood and on the development of atherosclerosis. RESULTS: Food intake, weight gain, blood lipid profile, and glycemia were similar between the groups. To evaluate leukocyte homing and activation, mice were injected with (99m)Tc-radiolabeled leukocytes, which showed enhanced leukocyte migration to the spleen and heart of A. blazei-supplemented animals. Analysis of the spleen showed higher levels of activation of neutrophils, NKT cells, and monocytes as well as increased production of TNF-α and IFN-γ. Circulating NKT cells and monocytes were also more activated in the supplemented group. Atherosclerotic lesion areas were larger in the aorta of supplemented mice and exhibited increased numbers of macrophages and neutrophils and a thinner fibrous cap. A. blazei-induced transcriptional upregulation of molecules linked to macrophage activation (CD36, TLR4), neutrophil chemotaxy (CXCL1), leukocyte adhesion (VCAM-1), and plaque vulnerability (MMP9) were seen after 12 weeks of supplementation. CONCLUSIONS: This is the first in vivo study showing that the immunostimulatory effect of A. blazei has proatherogenic repercussions. A. blazei enhances local and systemic inflammation, upregulating pro-inflammatory molecules, and enhancing leukocyte homing to atherosclerosis sites without affecting the lipoprotein profile.


Subject(s)
Agaricus/chemistry , Atherosclerosis/physiopathology , Dietary Supplements , Immunologic Factors/pharmacology , Inflammation/physiopathology , Animals , Aorta/drug effects , Aorta/physiopathology , Apolipoproteins E/deficiency , Atherosclerosis/immunology , CD36 Antigens/genetics , CD36 Antigens/metabolism , Cell Adhesion , Chemokine CXCL1/genetics , Chemokine CXCL1/metabolism , Disease Models, Animal , Fruiting Bodies, Fungal/chemistry , Inflammation/immunology , Interferon-gamma/immunology , Leukocytes/drug effects , Leukocytes/metabolism , Liver/drug effects , Liver/metabolism , Macrophage Activation/drug effects , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/metabolism , Mice , Mice, Knockout , Monocytes/immunology , Natural Killer T-Cells/drug effects , Natural Killer T-Cells/immunology , Neutrophils/immunology , Peroxidase/genetics , Peroxidase/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Spleen/immunology , Spleen/metabolism , Spleen/pathology , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/metabolism , Tumor Necrosis Factor-alpha/immunology , Up-Regulation , Vascular Cell Adhesion Molecule-1/genetics , Vascular Cell Adhesion Molecule-1/metabolism
4.
J Surg Res ; 171(2): e231-6, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21962813

ABSTRACT

BACKGROUND: Atherosclerosis is an inflammatory immune disease associated with lipid accumulation in the intima layer of arteries. The spleen plays an important immune function, but its influence in development of atherosclerosis remains unclear. Evaluation of the role of the spleen in atherosclerosis is justified due to the high frequency of total splenectomies. In this work, the effect of splenectomy on the development of atherosclerosis in apolipoprotein E (ApoE) deficient mice was investigated. METHODS: ApoE deficient mice were divided into a sham-operated control group (CT) and a splenectomized group (SP). Thirty days after surgery, animals were fed a high fat western diet. After 8 wk, mice were euthanized and their blood, heart, and aorta were subjected to analysis. Atherosclerotic lesion areas in the aortic root were stained with hematoxylin-eosin and quantified by morphometry. The atherosclerotic lesions in the thoracic and abdominal portions of aorta were determined by assessing the percentage of the luminal surface area stained by Sudan IV. Total serum cholesterol and anti-oxidized LDL antibodies were measured. RESULTS: Levels of total serum cholesterol did not vary significantly after splenectomy. Anti-oxidized LDL IgG antibodies were similar between groups. However, compared with the control group, lesions in the aortic root were significantly larger in splenectomized mice (P<0.01). These data were confirmed by the increase of atherosclerotic area in the thoracic and abdominal portions of aorta in splenectomized mice. CONCLUSIONS: These data indicate that splenectomy increases atherosclerotic lesions in ApoE deficient mice fed an atherogenic diet, suggesting an atheroprotector role of the spleen.


Subject(s)
Apolipoproteins E/genetics , Atherosclerosis/genetics , Atherosclerosis/physiopathology , Spleen/physiology , Splenectomy/adverse effects , Animals , Aortic Diseases/genetics , Aortic Diseases/physiopathology , Autoantibodies/blood , Body Weight/physiology , Cholesterol/blood , Diet, Atherogenic , Eating/physiology , Lipoproteins, LDL/blood , Lipoproteins, LDL/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Spleen/surgery
5.
Expert Rev Anti Infect Ther ; 7(7): 807-19, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19735223

ABSTRACT

Atherosclerosis and toxoplasmosis are two widely prevalent diseases worldwide. The relationship between these diseases is now being elucidated. Atherosclerosis is a disease with three main components: increased blood lipoprotein/cholesterol and their deposition in the arterial wall, an important Th1-mediated proinflammatory reaction and thrombogenic status. Toxoplasma gondii, in turn, is dependent on host cholesterol for optimal intracellular growth and replication. As a result, host cholesterol will be cleared from the blood, reducing plasma low-density lipoprotein, a crucial atherosclerosis risk factor. On the other hand, T. gondii infection elicits an important Th1 systemic inflammatory response in the host. Therefore, this additional proinflammatory stimulus may impose an enhanced pro-atherogenic environment in the host. As result, the association between these two diseases in one individual could change the course of atherosclerosis. In this review, we demonstrate that the host-parasite relationship is complex and that the outcome of each disease is dependent on the availability of intracellular cholesterol, as well as the intensity of the inflammatory reaction triggered by the parasite. We also discuss the possible clinical implications of these studies.


Subject(s)
Atherosclerosis/physiopathology , Cholesterol/metabolism , Host-Parasite Interactions/immunology , Inflammation/immunology , Toxoplasma/physiology , Toxoplasmosis/physiopathology , Animals , Atherosclerosis/immunology , Humans , Mice , Th1 Cells/immunology , Toxoplasma/metabolism , Toxoplasma/pathogenicity , Toxoplasmosis/immunology , Toxoplasmosis/parasitology
6.
Microbes Infect ; 10(3): 276-84, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18316222

ABSTRACT

Intracellular replication of Toxoplasma gondii requires cholesterol uptake by host cell low-density lipoprotein receptor (LDLr), a critical element in atherosclerosis. We evaluated host parasitism, inflammatory responses and development of atherosclerosis in LDLr knockout (LDLr(-/-)) and their controls C57BL/6 mice infected with T. gondii. Our results show that T. gondii cysts were reduced in LDLr(-/-) mice when compared to C57BL/6 mice. However, in presence of hypercholesterolemic diet, parasite growth in LDLr(-/-) mice was similar to that seen in infected C57BL/6 mice. In presence of a hypercholesterolemic diet, T. gondii infection leads to a 60% reduction of serum triacylglycerol, total and atherogenic lipoprotein cholesterol. When aortic valve lesion was analyzed, infected mice showed a reduction of atherosclerotic lesion area as well as CD36 expression. MCP-1, SRA-I, SRA-II, ICAM-1 and VCAM-1 mRNA expression was kept similar between infected and control groups. Thus, despite the intense inflammatory process, the drastic reduction in serum lipids seems to limit the development of atherosclerosis in LDLr(-/-) mice infected with T. gondii. In conclusion, our results indicate that T. gondii employs host LDLr to acquire cholesterol and favor its growth. However, in the presence of hypercholesterolemia, T. gondii parasites are able to acquire cholesterol-rich lipoproteins through an alternative host receptor, and overcome LDLr deficiency, favoring host parasitism and impairing lipid loading of foam cells.


Subject(s)
Receptors, LDL/physiology , Toxoplasma/physiology , Toxoplasmosis/parasitology , Animals , Aorta, Abdominal/immunology , Aorta, Abdominal/physiopathology , Aorta, Thoracic/immunology , Aorta, Thoracic/physiopathology , Aortic Valve/metabolism , Aortic Valve/pathology , Atherosclerosis/etiology , CD36 Antigens/metabolism , Cholesterol/blood , Host-Parasite Interactions , Lipid Metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, LDL/deficiency , Toxoplasmosis/complications , Toxoplasmosis/metabolism , Toxoplasmosis/physiopathology , Triglycerides/blood
7.
Infect Immun ; 72(6): 3571-6, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15155666

ABSTRACT

Toxoplasma gondii is an intracellular protozoan that elicits a potent inflammatory response during the acute phase of infection. Herein, we evaluate whether T. gondii infection alters the natural course of aortic lesions. ApoE knockout mice were infected with T. gondii, and at 5 weeks of infection, serum, feces, and liver cholesterol; aortic lesion size, cellularity, and inflammatory cytokines; and levels of serum nitrite and gamma interferon (IFN-gamma) were analyzed. Our results showed that serum cholesterol and atherogenic lipoproteins were reduced after T. gondii infection. The reduction of serum levels of total cholesterol and atherogenic lipoproteins was associated with increases in the aortic lesion area, numbers of inflammatory cells, and expression of monocyte chemoattractant protein 1 and inducible nitric oxide synthase mRNA in the site of lesions as well as elevated concentrations of IFN-gamma and nitrite in sera of T. gondii-infected animals. These results suggest that infection with T. gondii accelerates atherosclerotic development by stimulating the proinflammatory response and oxidative stress, thereby increasing the area of aortic lesion.


Subject(s)
Apolipoproteins E/genetics , Arteriosclerosis/etiology , Toxoplasma/pathogenicity , Toxoplasmosis, Animal/complications , Animals , Aorta/metabolism , Aorta/parasitology , Aorta/pathology , Apolipoproteins E/metabolism , Chemokine CCL2/metabolism , Cholesterol/blood , Interferon-gamma/metabolism , Lipoproteins/blood , Male , Mice , Mice, Knockout , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Nitrites/blood , Oxidative Stress , Toxoplasma/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...